Effect of atrial fibrillation duration on plasma von Willebrand factor level.

Waldemar E WysokinskiKevin P CohoonEwa A KonikRowlens M MelduniNaser M AmmashSamuel J AsirvathamRobert D McBane

Published in: European journal of haematology (2017)

von Willebrand Factor is steadily elevated throughout the course of dysrhythmia in NVAF patients treated with warfarin and in those with higher intensity of left atrium blood stasis.

Keyphrases

atrial fibrillation
oral anticoagulants
catheter ablation
left atrial appendage
direct oral anticoagulants
left atrial
venous thromboembolism
heart failure
high intensity
pulmonary artery
vena cava
coronary artery
acute coronary syndrome
left ventricular
pulmonary embolism